CIK 0001822791
- Non-accelerated filer
- Smaller reporting company
Clene Inc.
Sign in to watch- Ticker
- CLNN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 852828339
- Phone
- +1 801-676-9695
- Business address
- 6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UT, 84121
- Former names
- Chelsea Worldwide Inc.
- Open-market buys, last 90 days
- $34,240
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$34,240. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-04 | Ugwumba Chidozie 10% owner | Sale | −72,748 | $6.73 | $490K | 521,620 |
| 2025-12-03 | Ugwumba Chidozie 10% owner | Sale | −56,577 | $7.86 | $445K | 594,368 |
| 2025-08-21 | General Resonance LLC 10% owner | Sale | −3,401 | $5.34 | $18K | 704,591 |
| 2025-06-04 | General Resonance LLC 10% owner | Sale | −600 | $4.04 | $2K | 707,992 |
| 2025-06-02 | General Resonance LLC 10% owner | Sale | −600 | $4.12 | $2K | 708,592 |
| 2025-05-30 | General Resonance LLC 10% owner | Sale | −410 | $2.80 | $1K | 709,192 |
| 2025-05-29 | General Resonance LLC 10% owner | Sale | −410 | $2.73 | $1K | 709,602 |
| 2025-05-28 | General Resonance LLC 10% owner | Sale | −420 | $2.60 | $1K | 710,012 |
| 2025-05-27 | General Resonance LLC 10% owner | Sale | −420 | $2.45 | $1K | 710,432 |
| 2025-03-19 | General Resonance LLC 10% owner | Sale | −1,400 | $4.40 | $6K | 710,852 |
| 2025-03-18 | General Resonance LLC 10% owner | Sale | −1,333 | $4.45 | $6K | 712,252 |
| 2024-05-01 | General Resonance LLC 10% owner | Sale | −13,000 | $0.40 | $5K | 15,313,712 |
| 2024-04-30 | General Resonance LLC 10% owner | Sale | −13,000 | $0.42 | $5K | 15,326,712 |
| 2024-04-24 | General Resonance LLC 10% owner | Sale | −10,000 | $0.33 | $3K | 15,349,712 |
| 2024-04-09 | General Resonance LLC 10% owner | Sale | −7,500 | $0.39 | $3K | 15,443,212 |
| 2024-04-09 | General Resonance LLC 10% owner | Sale | −7,500 | $0.39 | $3K | 15,435,712 |
| 2024-04-09 | General Resonance LLC 10% owner | Sale | −7,500 | $0.38 | $3K | 15,428,212 |
| 2022-07-18 | Etherington Robert Dee Chief Executive Officer | Sale | −23,483 | $4.72 | $111K | 56,593 |
| 2022-06-16 | Mortenson Mark Chief Science Officer | Sale | −20,247 | $2.47 | $50K | 168,759 |
| 2022-05-16 | Glanzman Robert Chief Medical Officer | Sale | −4,717 | $2.03 | $10K | 10,564 |
Page 4 of 5 · 83 trades